FDA.reportPublic FDA data

Cryptococcus neoformans antigen IVD, control

Definition
A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of antigens from the yeast Cryptococcus neoformans in a clinical specimen.
GUDID devices
1
Last updated
2019-03-30 13:05:11

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
00816387020261IMMYImmuno-Mycologics, Inc.CB00502016-09-24